Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats

The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify... 1 The interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐hydroxytryptamine (5‐HT) release in the frontal cortex of the freely‐moving rat was assessed using the microdialysis technique. 2 The α2‐adrenoceptor antagonist, yohimbine (5.0 mg kg−1, i.p.) increased maximally the extracellular levels of 5‐HT in the rat frontal cortex by approximately 230% of the basal levels. 3 The α2‐adrenoceptor agonist, clonidine (30–100 μg kg−1, i.p.) decreased dose‐dependently the extracellular levels of 5‐HT in the rat frontal cortex by approximately 0–60% of the basal levels. A 5 min pretreatment with clonidine (50 μg kg−1, i.p.) prevented the yohimbine‐induced increase in the extracellular 5‐HT levels. 4 The benzodiazepine receptor agonist, diazepam (2.5 mg kg−1, i.p.) and the 5‐HT3 receptor antagonist, ondansetron (100 μg kg−1, i.p.) (5 min pretreatment) completely prevented the yohimbine (5.0 mg kg−1, i.p.)‐induced increases in the extracellular levels of 5‐HT. The 5‐HT1A receptor agonist, 8‐OH‐DPAT (0.32 mg kg−1, s.c.) partially antagonized the yohimbine response. 5 A 5 min pretreatment with the 5‐HT3/5‐HT4 receptor ligand R(+)‐zacopride (10 μg kg−1, i.p.) reversed the yohimbine (5.0 mg kg−1, i.p.)‐induced increase in the extracellular levels of 5‐HT to approximately 30% below the basal levels. A 5 min pretreatment with S(−)‐zacopride (100 μg kg−1, i.p.) failed to modify the response to yohimbine. 6 The present study provides evidence of the ability of the anxiogenic agent, yohimbine, to increase the activity of the central 5‐hydroxytryptaminergic system and the ability of clonidine and various anxiolytic and putative anxiolytic agents to prevent the yohimbine response. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Pharmacology Wiley

The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats

Download PDF
6 pages

Loading next page...
 
/lp/wiley/the-profiles-of-interaction-of-yohimbine-with-anxiolytic-and-putative-W5cD27XRqo

References (54)

Publisher
Wiley
Copyright
1993 British Pharmacological Society
ISSN
0007-1188
eISSN
1476-5381
DOI
10.1111/j.1476-5381.1993.tb13924.x
Publisher site
See Article on Publisher Site

Abstract

1 The interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐hydroxytryptamine (5‐HT) release in the frontal cortex of the freely‐moving rat was assessed using the microdialysis technique. 2 The α2‐adrenoceptor antagonist, yohimbine (5.0 mg kg−1, i.p.) increased maximally the extracellular levels of 5‐HT in the rat frontal cortex by approximately 230% of the basal levels. 3 The α2‐adrenoceptor agonist, clonidine (30–100 μg kg−1, i.p.) decreased dose‐dependently the extracellular levels of 5‐HT in the rat frontal cortex by approximately 0–60% of the basal levels. A 5 min pretreatment with clonidine (50 μg kg−1, i.p.) prevented the yohimbine‐induced increase in the extracellular 5‐HT levels. 4 The benzodiazepine receptor agonist, diazepam (2.5 mg kg−1, i.p.) and the 5‐HT3 receptor antagonist, ondansetron (100 μg kg−1, i.p.) (5 min pretreatment) completely prevented the yohimbine (5.0 mg kg−1, i.p.)‐induced increases in the extracellular levels of 5‐HT. The 5‐HT1A receptor agonist, 8‐OH‐DPAT (0.32 mg kg−1, s.c.) partially antagonized the yohimbine response. 5 A 5 min pretreatment with the 5‐HT3/5‐HT4 receptor ligand R(+)‐zacopride (10 μg kg−1, i.p.) reversed the yohimbine (5.0 mg kg−1, i.p.)‐induced increase in the extracellular levels of 5‐HT to approximately 30% below the basal levels. A 5 min pretreatment with S(−)‐zacopride (100 μg kg−1, i.p.) failed to modify the response to yohimbine. 6 The present study provides evidence of the ability of the anxiogenic agent, yohimbine, to increase the activity of the central 5‐hydroxytryptaminergic system and the ability of clonidine and various anxiolytic and putative anxiolytic agents to prevent the yohimbine response.

Journal

British Journal of Pharmacology – Wiley

Published: Nov 1, 1993

There are no references for this article.